Oct. 13, 2011, 12:19 PM
Biotech firm Medtox (MTOX -5.3%) trades lower after its Q3 missed estimates due to reduced order flow from its existing customers. EPS came in at $0.15 on sales of $27M, below analysts' expectations for an EPS of $0.17 on revenue of $28.5M.| Oct. 13, 2011, 12:19 PM
Currently, there's no company description for MTOX.
Industry: Medical Laboratories & Research
Country: United States
Other News & PR